{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:39Z","timestamp":1792788339330,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Copenhagen University","id":[{"id":"https:\/\/ror.org\/035b05819","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"DOI":"10.1186\/s13073-026-01708-9","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:16:43Z","timestamp":1784222203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A short-term randomized clinical trial testing feasibility of and physiological responses to a Ruminococcus torques strain in healthy overweight humans"],"prefix":"10.1186","volume":"18","author":[{"given":"Joachim","family":"G\u00e6de","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Stankevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e6rke Smidt","family":"Gasbjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matej","family":"Oresic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuulia","family":"Hy\u00f6tyl\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Brix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asger B.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorte Aalund","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Rabing Brix","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Brandslund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolette","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Juul","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip Krag","family":"Knop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluf","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"19","key":"1708_CR1","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, Eliaschewitz FG, J\u00f3dar E, Leiter LA, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375(19):1834\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1607141. PubMed PMID: 27633186.","journal-title":"N Engl J Med"},{"issue":"10278","key":"1708_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","volume":"397","author":"M Davies","year":"2021","unstructured":"Davies M, F\u00e6rch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L, et al. Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet Lond Engl. 2021;397(10278):971\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(21)00213-0. PubMed PMID: 33667417.","journal-title":"Lancet Lond Engl"},{"issue":"10148","key":"1708_CR3","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0140-6736(18)31773-2","volume":"392","author":"PM O\u2019Neil","year":"2018","unstructured":"O\u2019Neil PM, Birkenfeld AL, McGowan B, Mosenzon O, Pedersen SD, Wharton S, et al. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. Lancet Lond Engl. 2018;392(10148):637\u201349. https:\/\/doi.org\/10.1016\/S0140-6736(18)31773-2. PubMed PMID: 30122305.","journal-title":"Lancet Lond Engl"},{"issue":"11","key":"1708_CR4","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989\u20131002. https:\/\/doi.org\/10.1056\/NEJMoa2032183. PubMed PMID: 33567185.","journal-title":"N Engl J Med"},{"issue":"1","key":"1708_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/nu12010124","volume":"12","author":"C Tenorio-Jim\u00e9nez","year":"2020","unstructured":"Tenorio-Jim\u00e9nez C, Mart\u00ednez-Ram\u00edrez MJ, Gil \u00c1, G\u00f3mez-Llorente C. Effects of probiotics on metabolic syndrome: a systematic review of randomized clinical trials. Nutrients. 2020;12(1):124. https:\/\/doi.org\/10.3390\/nu12010124. PubMed PMID: 31906372.","journal-title":"Nutrients"},{"issue":"10","key":"1708_CR6","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.2337\/dc14-2690","volume":"38","author":"MC Simon","year":"2015","unstructured":"Simon MC, Strassburger K, Nowotny B, Kolb H, Nowotny P, Burkart V, et al. Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of concept. Diabetes Care. 2015;38(10):1827\u201334. https:\/\/doi.org\/10.2337\/dc14-2690. PubMed PMID: 26084343.","journal-title":"Diabetes Care"},{"key":"1708_CR7","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1136\/gutjnl-2020-323297","volume":"71","author":"A Koopen","year":"2021","unstructured":"Koopen A, Witjes J, Wortelboer K, Majait S, Prodan A, Levin E, et al. Duodenal Anaerobutyricum soehngenii infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over study. Gut. 2021;71:1577. https:\/\/doi.org\/10.1136\/gutjnl-2020-323297. PubMed PMID: 34697034.","journal-title":"Gut"},{"issue":"1","key":"1708_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41522-020-0127-0","volume":"6","author":"PW Gilijamse","year":"2020","unstructured":"Gilijamse PW, Hartstra AV, Levin E, Wortelboer K, Serlie MJ, Ackermans MT, et al. Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose-response effects on glucose metabolism in human subjects with metabolic syndrome. NPJ Biofilms Microbiomes. 2020;6(1):16. https:\/\/doi.org\/10.1038\/s41522-020-0127-0. PubMed PMID: 32221294.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"7","key":"1708_CR9","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","volume":"25","author":"C Depommier","year":"2019","unstructured":"Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096\u2013103. https:\/\/doi.org\/10.1038\/s41591-019-0495-2. PubMed PMID: 31263284.","journal-title":"Nat Med"},{"issue":"1","key":"1708_CR10","doi-asserted-by":"publisher","first-page":"e001319","DOI":"10.1136\/bmjdrc-2020-001319","volume":"8","author":"F Perraudeau","year":"2020","unstructured":"Perraudeau F, McMurdie P, Bullard J, Cheng A, Cutcliffe C, Deo A, et al. Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation. BMJ Open Diabetes Res Care. 2020;8(1):e001319. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001319. PubMed PMID: 32675291.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1708_CR11","doi-asserted-by":"publisher","first-page":"1220044","DOI":"10.3389\/fendo.2023.1220044","volume":"14","author":"M Yang","year":"2023","unstructured":"Yang M, Wang JH, Shin JH, Lee D, Lee SN, Seo JG, et al. Pharmaceutical efficacy of novel human-origin Faecalibacterium prausnitzii strains on high-fat-diet-induced obesity and associated metabolic disorders in mice. Front Endocrinol. 2023;14:1220044. https:\/\/doi.org\/10.3389\/fendo.2023.1220044. PubMed PMID: 37711887.","journal-title":"Front Endocrinol"},{"issue":"5","key":"1708_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41564-021-00880-5","volume":"6","author":"HS Yoon","year":"2021","unstructured":"Yoon HS, Cho CH, Yun MS, Jang SJ, You HJ, Kim JH, et al. Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice. Nat Microbiol. 2021;6(5):563\u201373. https:\/\/doi.org\/10.1038\/s41564-021-00880-5. PubMed PMID: 33820962.","journal-title":"Nat Microbiol"},{"issue":"8","key":"1708_CR13","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1038\/s41564-025-02064-x","volume":"10","author":"Y Fan","year":"2025","unstructured":"Fan Y, Lyu L, Vazquez-Uribe R, Zhang W, Bongers M, Koulouktsis A, et al. Polypeptides synthesized by common bacteria in the human gut improve rodent metabolism. Nat Microbiol. 2025;10(8):1918\u201339. https:\/\/doi.org\/10.1038\/s41564-025-02064-x. PubMed PMID: 40745048; PubMed Central PMCID: PMC12313525.","journal-title":"Nat Microbiol"},{"issue":"8","key":"1708_CR14","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.cmet.2024.07.004","volume":"36","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang X, Lin J, Liu J, Wang K, Nie Q, et al. A microbial metabolite inhibits the HIF-2\u03b1-ceramide pathway to mediate the beneficial effects of time-restricted feeding on MASH. Cell Metab. 2024;36(8):1823-1838.e6. https:\/\/doi.org\/10.1016\/j.cmet.2024.07.004. PubMed PMID: 39079531.","journal-title":"Cell Metab"},{"key":"1708_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-026-06751-0","author":"J G\u00e6de","year":"2026","unstructured":"G\u00e6de J, Fan Y, Lyu L, Gasbjerg LS, Rossing P, Hartmann B, et al. A randomised clinical trial testing the safety of and metabolic responses to short-term duodenal infusion of recombinant RORDEP1 in healthy men. Diabetologia. 2026. https:\/\/doi.org\/10.1007\/s00125-026-06751-0. PubMed PMID: 42177350.","journal-title":"Diabetologia"},{"issue":"9","key":"1708_CR16","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462\u201370. https:\/\/doi.org\/10.2337\/diacare.22.9.1462. PubMed PMID: 10480510.","journal-title":"Diabetes Care"},{"issue":"4","key":"1708_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2337\/diab.43.4.535","volume":"43","author":"C Orskov","year":"1994","unstructured":"Orskov C, Rabenh\u00f8j L, Wettergren A, Kofod H, Holst JJ. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes. 1994;43(4):535\u20139. https:\/\/doi.org\/10.2337\/diab.43.4.535. PubMed PMID: 8138058.","journal-title":"Diabetes"},{"issue":"4","key":"1708_CR18","doi-asserted-by":"publisher","first-page":"E1062","DOI":"10.1152\/ajpendo.00450.2006","volume":"292","author":"B Sloth","year":"2007","unstructured":"Sloth B, Holst JJ, Flint A, Gregersen NT, Astrup A. Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects. Am J Physiol Endocrinol Metab. 2007;292(4):E1062\u20138. https:\/\/doi.org\/10.1152\/ajpendo.00450.2006. PubMed PMID: 17148749.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"8","key":"1708_CR19","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1210\/jc.2011-0266","volume":"96","author":"O Lindgren","year":"2011","unstructured":"Lindgren O, Carr RD, Deacon CF, Holst JJ, Pacini G, Mari A, et al. Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans. J Clin Endocrinol Metab. 2011;96(8):2519\u201324. https:\/\/doi.org\/10.1210\/jc.2011-0266. PubMed PMID: 21593115.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1708_CR20","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1530\/EJE-13-0941","volume":"170","author":"MJ Bak","year":"2014","unstructured":"Bak MJ, Albrechtsen NW, Pedersen J, Hartmann B, Christensen M, Vilsb\u00f8ll T, et al. Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans. Eur J Endocrinol. 2014;170(4):529\u201338. https:\/\/doi.org\/10.1530\/EJE-13-0941. PubMed PMID: 24412928.","journal-title":"Eur J Endocrinol"},{"key":"1708_CR21","doi-asserted-by":"publisher","first-page":"115553","DOI":"10.1016\/j.bone.2020.115553","volume":"140","author":"MM Helsted","year":"2020","unstructured":"Helsted MM, Gasbjerg LS, Lanng AR, Bergmann NC, Stensen S, Hartmann B, et al. The role of endogenous GIP and GLP-1 in postprandial bone homeostasis. Bone. 2020;140:115553. https:\/\/doi.org\/10.1016\/j.bone.2020.115553. PubMed PMID: 32730920.","journal-title":"Bone"},{"issue":"4","key":"1708_CR22","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41370-024-00680-z","volume":"34","author":"BS Karthikeyan","year":"2024","unstructured":"Karthikeyan BS, Hy\u00f6tyl\u00e4inen T, Ghaffarzadegan T, Triplett E, Ore\u0161i\u010d M, Ludvigsson J. Prenatal exposure to environmental contaminants and cord serum metabolite profiles in future immune-mediated diseases. J Expo Sci Environ Epidemiol. 2024;34(4):647\u201358. https:\/\/doi.org\/10.1038\/s41370-024-00680-z.","journal-title":"J Expo Sci Environ Epidemiol"},{"issue":"1","key":"1708_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-022-01148-1","volume":"15","author":"F Thirion","year":"2023","unstructured":"Thirion F, Sellebjerg F, Fan Y, Lyu L, Hansen TH, Pons N, et al. The gut microbiota in multiple sclerosis varies with disease activity. Genome Med. 2023;15(1):1. https:\/\/doi.org\/10.1186\/s13073-022-01148-1. PubMed PMID: 36604748.","journal-title":"Genome Med"},{"key":"1708_CR24","doi-asserted-by":"crossref","unstructured":"Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnetjournal Vol 17 No 1 Gener Seq Data Anal - 1014806ej171200. 2011 May 2. Available from: https:\/\/journal.embnet.org\/index.php\/embnetjournal\/article\/view\/200,","DOI":"10.14806\/ej.17.1.200"},{"issue":"7","key":"1708_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581\u20133. https:\/\/doi.org\/10.1038\/nmeth.3869. PubMed PMID: 27214047.","journal-title":"Nat Methods"},{"issue":"5","key":"1708_CR26","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41564-023-01355-5","volume":"8","author":"Y Fan","year":"2023","unstructured":"Fan Y, St\u00f8ving RK, Berreira Ibraim S, Hy\u00f6tyl\u00e4inen T, Thirion F, Arora T, et al. The gut microbiota contributes to the pathogenesis of anorexia nervosa in humans and mice. Nat Microbiol. 2023;8(5):787\u2013802. https:\/\/doi.org\/10.1038\/s41564-023-01355-5. PubMed PMID: 37069399.","journal-title":"Nat Microbiol"},{"issue":"11","key":"1708_CR27","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1210\/en.2015-1321","volume":"156","author":"CA Brighton","year":"2015","unstructured":"Brighton CA, Rievaj J, Kuhre RE, Glass LL, Schoonjans K, Holst JJ, et al. Bile acids trigger GLP-1 release predominantly by accessing basolaterally located G Protein-coupled bile acid receptors. Endocrinology. 2015;156(11):3961\u201370. https:\/\/doi.org\/10.1210\/en.2015-1321. PubMed PMID: 26280129.","journal-title":"Endocrinology"},{"key":"1708_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jnutbio.2016.03.006","volume":"32","author":"D Ripken","year":"2016","unstructured":"Ripken D, van der Wielen N, Wortelboer HM, Meijerink J, Witkamp RF, Hendriks HFJ. Nutrient-induced glucagon like peptide-1 release is modulated by serotonin. J Nutr Biochem. 2016;32:142\u201350. https:\/\/doi.org\/10.1016\/j.jnutbio.2016.03.006. PubMed PMID: 27142747.","journal-title":"J Nutr Biochem"},{"issue":"1","key":"1708_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41413-022-00219-8","volume":"10","author":"S Bolamperti","year":"2022","unstructured":"Bolamperti S, Villa I, Rubinacci A. Bone remodeling: an operational process ensuring survival and bone mechanical competence. Bone Res. 2022;10(1):48. https:\/\/doi.org\/10.1038\/s41413-022-00219-8. PubMed PMID: 35851054.","journal-title":"Bone Res"},{"key":"1708_CR30","doi-asserted-by":"publisher","first-page":"170197","DOI":"10.1016\/j.peptides.2019.170197","volume":"125","author":"S Stensen","year":"2020","unstructured":"Stensen S, Gasbjerg LS, Helsted MM, Hartmann B, Christensen MB, Knop FK. GIP and the gut-bone axis - Physiological, pathophysiological and potential therapeutic implications. Peptides. 2020;125:170197. https:\/\/doi.org\/10.1016\/j.peptides.2019.170197. PubMed PMID: 31715213.","journal-title":"Peptides"},{"issue":"5","key":"1708_CR31","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/ijms22052719","volume":"22","author":"DI Jang","year":"2021","unstructured":"Jang DI, Lee AH, Shin HY, Song HR, Park JH, Kang TB, et al. The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics. Int J Mol Sci. 2021;22(5):2719. https:\/\/doi.org\/10.3390\/ijms22052719. PubMed PMID: 33800290; PubMed Central PMCID: PMC7962638.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1708_CR32","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1186\/s12967-025-07192-w","volume":"23","author":"Y Lou","year":"2025","unstructured":"Lou Y, Lv Y, Wang X, Luo Y, Lou J, Yu Y, et al. Ruminococcus torques ameliorates the inflammation bowel disease and gut barrier dysfunction by modulating gut microbiota and bile acid metabolism. J Transl Med. 2025;23(1):1162. https:\/\/doi.org\/10.1186\/s12967-025-07192-w. PubMed PMID: 41131583; PubMed Central PMCID: PMC12548225.","journal-title":"J Transl Med"},{"key":"1708_CR33","unstructured":"UCPH. A short-term randomized clinical trial testing feasibility and physiological responses of a Ruminococcus torques strain in healthy overweight humans. Project: PRJEB107618. European Nucleotide Archive 2026. Available from https:\/\/www.ebi.ac.uk\/ena\/browser\/view\/PRJEB107618."},{"key":"1708_CR34","unstructured":"UCPH. MassIVE. Data code: MSV000101306. Available at https:\/\/massive.ucsd.edu\/ProteoSAFe\/static\/massive.jsp?redirect=auth."}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-026-01708-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-026-01708-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-026-01708-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:02:09Z","timestamp":1791910929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13073-026-01708-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1708"],"URL":"https:\/\/doi.org\/10.1186\/s13073-026-01708-9","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ethics Committee of Capital Region of Denmark registration number H-21075670), and the clinical trial is registered at ClinicalTrials.gov (NCT05448274). The study was conducted in accordance with the Helsinki Declaration. Written informed consent was obtained from all study participants.","order":1,"name":"Ethics","label":"Ethics approval and informed consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ABL has received research support from Novo Nordisk and honoraria as a speaker for Boehringer Ingelheim, Novo Nordisk and AstraZeneca and has served on the advisory board of Zealand Pharma. FKK is employed by Novo Nordisk. OP and YF are co-founders of GutCRINE. The remaining authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"150"}}